AbbVie (ABBV) FY2022 results: revenue $58.1 billion, up 3.3% on the year
AbbVie Inc. (ABBV) reported revenue of $58.1 billion for fiscal 2022, the year ended 31 December 2022, up 3.3% on the year before. Net income was $11.8 billion, up 2.5%, and diluted earnings per share $6.63. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2023.
Revenue
$58.1 billion
+3.3% on the year
FY2015FY2022
Operating margin
31.2%
31.9% a year earlier
FY2015FY2022
Net income
$11.8 billion
+2.5% on the year
FY2015FY2022
Diluted EPS
$6.63
+2.8% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
24,943
22,777
17,588
+9.5%
Capital expenditure
695
787
798
-11.7%
Free cash flow
24,248
21,990
16,790
+10.3%
Free cash flow margin
41.8%
39.1%
36.7%
Cash from investing
-623
-2,344
-37,557
Cash from financing
-24,803
-19,039
-11,501
Depreciation and amortisation
8,467
8,521
6,471
-0.6%
Share-based compensation
671
692
753
-3.0%
Buybacks
1,487
934
978
+59.2%
Dividends paid
10,043
9,261
7,716
+8.4%
Dividend per share
$5.71
$5.31
$4.84
+7.5%
Diluted shares, weighted
1,778m
1,777m
1,673m
+0.1%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
17,254
15,408
13,076
+12.0%
Non-controlling interest
33.0
28.0
21.0
+17.9%
Short-term borrowings
1.0
n/a
n/a
Debt
63,128
76,684
86,056
-17.7%
Operating lease liabilities
754
713
832
+5.8%
Finance lease liabilities
17.0
25.0
21.0
-32.0%
Other liabilities
57,618
53,671
50,559
+7.4%
Total liabilities and equity
138,805
146,529
150,565
-5.3%
Fixed assets
4,935
5,110
5,248
-3.4%
Goodwill
32,156
32,379
33,124
-0.7%
Intangible assets
67,439
75,951
82,876
-11.2%
Investments
269
361
323
-25.5%
Cash and equivalents
9,201
9,746
8,449
-5.6%
Receivables
11,254
9,977
8,822
+12.8%
Inventory
3,579
3,128
3,310
+14.4%
Other assets
9,972
9,877
8,413
+1.0%
Total assets
138,805
146,529
150,565
-5.3%
10-K for the year ended 31 December 2022, filed 17 February 2023: the filing.